Laboratory of Food Quality Management, Department of Food Sciences, FARAH - Veterinary Public Health, University of Liège, Liège 4000, Belgium; Intestinal Regenerative Medicine Lab, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.
Laboratory of Food Quality Management, Department of Food Sciences, FARAH - Veterinary Public Health, University of Liège, Liège 4000, Belgium.
Microbiol Res. 2024 Aug;285:127778. doi: 10.1016/j.micres.2024.127778. Epub 2024 May 28.
Probiotics are host-friendly microorganisms that can have important health benefits in the human gut microbiota as dietary supplements. Maintaining a healthy gut microbial balance relies on the intricate interplay among the intestinal microbiota, metabolic activities, and the host's immune response. This study aims to explore if a mixture of Heyndrickxia coagulans [ATB-BCS-042] and Lacticaseibacillus casei [THT-030-401] promotes in vitro this balance in representative gut microbiota from healthy individuals using the Triple-SHIME® (Simulation of the Human Intestinal Microbial Ecosystem). Metataxonomic analysis of the intestinal microbes revealed that the probiotic mix was not causing important disruptions in the biodiversity or microbial composition of the three simulated microbiota. However, some targeted populations analyzed by qPCR were found to be disrupted at the end of the probiotic treatment or after one week of washout. Populations such as Cluster IV, Cluster XVIa, and Roseburia spp., were increased indicating a potential gut health-promoting butyrogenic effect of the probiotic supplementation. In two of the systems, bifidogenic effects were observed, while in the third, the treatment caused a decrease in bifidobacteria. For the health-detrimental biomarker Escherichia-Shigella, a mild decrease in all systems was observed in the proximal colon sections, but these genera were highly increased in the distal colon sections. By the end of the washout, Bacteroides-Prevotella was found consistently boosted, which could have inflammatory consequences in the intestinal context. Although the probiotics had minimal influence on most quantified metabolites, ammonia consistently decreased after one week of daily probiotic supplementation. In reporter gene assays, aryl hydrocarbon receptor (AhR) activation was favored by the metabolic output obtained from post-treatment periods. Exposure of a human intestinal cell model to fermentation supernatant obtained after probiotic supplementation induced a trend to decrease the mRNA expression of immunomodulatory cytokines (IL-6, IL-8). Overall, with some exceptions, a positive impact of H. coagulans and L. casei probiotic mix was observed in the three parallel experiments, despite inter-individual differences. This study might serve as an in vitro pipeline for the impact assessment of probiotic combinations on the human gut microbiota.
益生菌是宿主友好型微生物,作为膳食补充剂,可以对人类肠道微生物群产生重要的健康益处。维持健康的肠道微生物平衡依赖于肠道微生物群、代谢活动和宿主免疫反应之间的复杂相互作用。本研究旨在探讨海氏肠球菌[ATB-BCS-042]和干酪乳杆菌[THT-030-401]的混合物是否通过 Triple-SHIME®(人类肠道微生物生态系统模拟)促进来自健康个体的代表性肠道微生物群的这种平衡。肠道微生物的分类组学分析表明,益生菌混合物不会对三种模拟微生物群的生物多样性或微生物组成造成重要破坏。然而,在益生菌治疗结束或一周冲洗后,通过 qPCR 分析发现一些靶向种群被破坏。一些种群,如 IV 群、XVIa 群和罗斯伯里氏菌属,增加表明益生菌补充具有潜在的促进肠道健康的产丁酸作用。在两个系统中观察到双歧杆菌效应,而在第三个系统中,治疗导致双歧杆菌减少。对于健康有害的生物标志物大肠杆菌-志贺氏菌,在所有系统的近端结肠部分都观察到轻微减少,但在远端结肠部分这些菌属高度增加。在冲洗结束时,发现拟杆菌-普雷沃氏菌始终增加,这可能在肠道环境中产生炎症后果。尽管益生菌对大多数定量代谢物的影响很小,但在每天补充益生菌一周后,氨一直下降。在报告基因测定中,芳基烃受体(AhR)的激活受到治疗后代谢产物的影响。将发酵上清液暴露于添加益生菌后的人肠道细胞模型中,可诱导免疫调节细胞因子(IL-6、IL-8)的 mRNA 表达下降的趋势。总体而言,尽管存在个体间差异,但在三个平行实验中,海氏肠球菌和干酪乳杆菌益生菌混合物表现出积极影响。这项研究可能为评估益生菌组合对人类肠道微生物群的影响提供体外研究途径。